|
| |
Produced through a proprietary fermentation process, PEAK ATP® delivers the exact molecule the human body needs to create energy. Extensive scientific evidence shows that PEAK ATP has a dramatic effect on circulation without adversely affecting heart rate or blood pressure. As circulation is the primary vehicle for delivering glucose, nutrients and oxygen to all tissue cells, PEAK ATP has applications for energy, athletic performance and anti-aging.
While ATP powers nearly every human function, ATP levels decline with age and in response to stress. Low ATP stores are associated with impaired organ and muscle function. Research shows that PEAK ATP can elevate the body's intracellular and extracellular levels of ATP.
A large volume of scientific, pre-clinical and human clinical data demonstrates the benefits of exogenous administration of ATP for a variety of human indications. A number of studies researching ATP's effects on the seriously ill have found that subjects reported having more energy, less fatigue and an improved quality of life after being treated with ATP.1,2 Supplementing with ATP has also been observed to produce the same increase in human skeletal muscle blood flow while resting as that seen in exercising muscles, benefiting muscle growth, strength and recovery.3 Additionally, animal studies have shown that ATP regulates the tone of the blood vessels to reduce pulmonary and vascular resistance, allowing more blood flow to peripheral and cerebral sites.4,5
PEAK ATP is the first legitimate entry of ATP - adenosine triphosphate - into the marketplace. PEAK ATP demonstrates TSI's commitment to developing and producing groundbreaking ingredients to provide our manufacturing partners a significant advantage in bringing sound, efficacious products to market.
For more information visit peakatp.com
References:
1 Agteresch H J et al. Beneficial Effects of Adenosine Triphosphate on Quality of Life in Patients with Advanced Lung Cancer: A Randomized Clinical Trial. Proc. Amer. Soc. Clin. Oncology.2002; 20:371-378.
2 Agteresch H J et al. Randomized Clinical Trial: Adenosine 5'-Triphosphate in Patients with Advanced Non-Small-Cell Lung Cancer. J Natl. Cancer Inst.2000; 92: 321-328.
3 Gonzalez-Alonso J et al. Erythrocyte and the Regulation of Human Skeletal Muscle Blood Flow and Oxygen Delivery: Role of Circulating ATP. Circulation Research. 2002; 91:1046-1055.
4 Kichenin K et al. Cardiovascular and Pulmonary Response to Oral Administration of ATP in Rabbits. J. Appl. Physiol. 2000; 88:1962-1968.
5 Forrester A M et al. Effect of Adenosine Triphophate and Some Derivatives on Cerebral Blood Flow and Metabolism. J. Physiol. 1979; 296:343-355.
|
|
|
|
